Atrial fibrillation with RVR
Revision as of 18:21, 8 September 2014 by Ostermayer (talk | contribs)
Unstable
- Synchronized cardioversion (100-200J)
- Indications: ischemic CP, SBP < 90, acute pulmonary edema, AMS
- If shock doesn't work:
- Verify not preexcitation
- Incr diastolic BP to perfuse the heart
- Push-dose phenyleprhine
- Will maintain BP when give rate-control meds
- 50-200mcg q2-5min w/ goal DBP >60
- Push-dose phenyleprhine
- Amiodarone 150mg over 10min OR diltiazem 2.5mg/min until HR<100 or max 50mg
Stable
- Goal <120bpm
- Make sure you not slowing down a normal physiologic response (e.g. fever, hypoxia, etc)
Cardioversion
- Consider for:
- Symptoms <48hr
- New diagnosis
- No history of similar episodes
- No LV dysfunction
- No mitral valve disease
- No prior thromboembolic event
- Already Anticoagulated
Calcium-Channel Blockers
Contraindications:
- Decompensated heart failure
- Preexcitation (especially in pediatrics)
- Significant hypotension
Diltiazem
- Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
- If, after 15min 1st dose is tolerated but inadequate re-bolus 0.35 mg/kg
- If patient responds start infusion at 5-15mg/hr or give PO dilt 30mg QID
Beta-Blockers
- Particularly useful when A-fib a/w exercise, after acute MI, or w/ thyrotoxicosis
- Also long-term beta blocker improves patient survival whereas non-dihydropyridine calcium channel blockers may even worsen outcomes. Important to consider if a patient will most likely be started on a beta blocker upon discharge then strongly consider using the agent for acute conversion if they do not have any relative contraindications.[2][3]
Contraindications:
- COPD
- Asthma
- Decompensated heart failure
- Hypotension
Metoprolol
- Bolus 2.5-5mg IVP over 2min q5min up to 3 doses
- If patient responds orally load with 25-50mg
Esmolol
- Use if unsure whether patient will tolerate a beta blocker since the duration of action is only 10 minutes
- Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
- If, after 4min response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
- If, after 4min response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
- If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
Digoxin
- Consider as initial therapy for pts with LV dysfunction who:
- Do not achieve rate control targets on beta blockers alone
- Cannot tolerate addition of or increased doses of beta blocker due to decompensated CHF
- Would have digoxin added anyway to improve CHF symptoms independent of A-fib
- Consider as initial therapy in pts with severe hypotension
- Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
- May take up to 6-8 hours to work
- Dosing
- 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
- Adjust dose in presence of renal failure, amiodarone, etc
Amiodarone
- Consider for pts with decompensated heart failure or those with accessory pathways
- 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
- Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24hr via continuous infusion or in divided oral doses
Stable and Asymptomatic
If mild or no symptoms and pulse only mildly elevated (<120bpm) ok to manage with PO meds
Evidence of preexcitation
- Avoid AV nodal agents
- Unstable:
- Unsynchronized cardioversion (200J)
- Procainamide (if cardioversion unsuccessful)
- 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
- Stable:
- Try to avoid cardioversion without adequate anticoagulation
See Also
External Links
[ALiEM - BB vs CCB] [Crashing Afib - EMCrit]
Source
- ↑ Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011 May 10;342:d2549
- ↑ Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999 Jun 12;353(9169):2001-7
- ↑ Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II–DAVIT II). Am J Cardiol. 1990 Oct 1;66(10):779-85
